Glenview Trust Co Takes Position in Humana Inc. $HUM

Key Points

• Glenview Trust Co. bought 43,688 Humana shares during the second quarter, worth approximately $17.35 million, while institutional investors collectively own 92.38% of the company.
• Humana reported quarterly earnings of $7.61 per share, beating estimates of $7.27, while revenue rose 26.2% year over year to $40.89 billion.
• Analyst sentiment is mixed: the stock has an overall “Hold” rating and an average price target of $403.91, compared with a recent share price of $392.72.

Glenview Trust Co purchased a new stake in Humana Inc. (NYSE:HUM - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 43,688 shares of the insurance provider's stock, valued at approximately $17,354,000.

Other institutional investors have also recently added to or reduced their stakes in the company. Montag A & Associates Inc. raised its holdings in Humana by 1,880.0% in the 4th quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider's stock valued at $25,000 after buying an additional 94 shares during the period. Johnson Financial Group Inc. purchased a new position in Humana during the second quarter worth about $26,000. Fideuram Asset Management Ireland dac acquired a new stake in shares of Humana during the fourth quarter valued at about $27,000. Trust Co. of Vermont acquired a new stake in shares of Humana during the second quarter valued at about $28,000. Finally, Reflection Asset Management purchased a new stake in shares of Humana in the 4th quarter valued at approximately $29,000. Hedge funds and other institutional investors own 92.38% of the company's stock.

Humana Stock Performance

Shares of HUM stock opened at $392.72 on Friday. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.62. Humana Inc. has a 52 week low of $163.11 and a 52 week high of $428.88. The stock has a market capitalization of $47.16 billion, a PE ratio of 37.15, a P/E/G ratio of 2.23 and a beta of 0.72. The firm has a 50 day moving average of $385.08 and a two-hundred day moving average of $287.78.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings results on Wednesday, July 29th. The insurance provider reported $7.61 EPS for the quarter, topping the consensus estimate of $7.27 by $0.34. Humana had a net margin of 0.88% and a return on equity of 11.20%. The business had revenue of $40.89 billion during the quarter, compared to the consensus estimate of $40.58 billion. During the same quarter in the previous year, the firm posted $6.27 earnings per share. The company's quarterly revenue was up 26.2% compared to the same quarter last year. On average, research analysts predict that Humana Inc. will post 9.12 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts have commented on HUM shares. Truist Financial upped their price target on Humana from $320.00 to $415.00 and gave the stock a "hold" rating in a research note on Tuesday, July 14th. The Goldman Sachs Group lifted their price objective on Humana from $158.00 to $195.00 and gave the company a "sell" rating in a research note on Thursday, April 30th. Deutsche Bank Aktiengesellschaft began coverage on Humana in a report on Thursday, July 30th. They issued a "hold" rating on the stock. Raymond James Financial lowered Humana from an "outperform" rating to a "market perform" rating in a research note on Thursday, July 30th. Finally, Robert W. Baird set a $390.00 target price on Humana in a report on Thursday, July 30th. Fourteen research analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $403.91.

About Humana

Humana Inc NYSE: HUM is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana's products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source